Regenicin, Inc.RGINCash flow

Market cap
$15.35K
P/E ratio
2011/092012/092013/092014/092015/092016/092017/092018/092019/092020/092021/09
Stock-based compensation867,7261127,55632,36567,895--30,824--
Cash from operations -1,774,552-1,058,929-685,142-211,845-1,996,685-693,272-311,705-133,721-126,862-123,199-24,107
Capital expenditures33-3,007,500--------
Cash from investing -3,007,500-3,007,500-3,007,500-4-67,26867,268----
Proceeds from issuance of term debt, net123100,000-------
Cash from financing 567189,837-532,430-81,99044,791117,222124,975123,75024,600
Free cash flow--------